Spyros Deftereos

2.8k total citations · 1 hit paper
51 papers, 2.0k citations indexed

About

Spyros Deftereos is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Spyros Deftereos has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 10 papers in Pathology and Forensic Medicine and 9 papers in Molecular Biology. Recurrent topics in Spyros Deftereos's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (6 papers) and Dermatological and Skeletal Disorders (4 papers). Spyros Deftereos is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (6 papers) and Dermatological and Skeletal Disorders (4 papers). Spyros Deftereos collaborates with scholars based in Greece, United States and Belgium. Spyros Deftereos's co-authors include Alexios S. Antonopoulos, George-Angelo Papamikroulis, Dimitris Tousoulis, Georgia Vogiatzi, Spyridon Papaioannou, Sotirios Tsalamandris, Evangelos Oikonomou, Andreas Persidis, Christos Andronis and Maria Tsironi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Annals of the New York Academy of Sciences.

In The Last Decade

Spyros Deftereos

51 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

2019 942 citations Spyros Deftereos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Spyros Deftereos Greece	17	465	405	358	332	233	51	2.0k
Keisuke Ishizawa Japan	28	643 1.4×	217 0.5×	196 0.5×	325 1.0×	163 0.7×	149	2.5k
Nishit B. Modi United States	29	531 1.1×	177 0.4×	148 0.4×	331 1.0×	307 1.3×	91	2.7k
Yuji Kumagai Japan	25	493 1.1×	151 0.4×	134 0.4×	155 0.5×	123 0.5×	127	2.0k
Jia Jia China	28	702 1.5×	120 0.3×	180 0.5×	225 0.7×	349 1.5×	150	2.5k
Martin Kaufmann Canada	29	513 1.1×	147 0.4×	632 1.8×	297 0.9×	141 0.6×	129	3.8k
Bart A. Ploeger Netherlands	26	630 1.4×	77 0.2×	284 0.8×	81 0.2×	85 0.4×	67	2.3k
Feng Zheng China	24	685 1.5×	370 0.9×	121 0.3×	71 0.2×	276 1.2×	54	2.5k
Jie Ding China	33	738 1.6×	121 0.3×	256 0.7×	60 0.2×	459 2.0×	165	3.9k
Vangelis G. Manolopoulos Greece	28	1.2k 2.5×	68 0.2×	323 0.9×	97 0.3×	160 0.7×	135	3.2k

Countries citing papers authored by Spyros Deftereos

Since Specialization

Citations

This map shows the geographic impact of Spyros Deftereos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spyros Deftereos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spyros Deftereos more than expected).

Fields of papers citing papers by Spyros Deftereos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spyros Deftereos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spyros Deftereos. The network helps show where Spyros Deftereos may publish in the future.

Co-authorship network of co-authors of Spyros Deftereos

This figure shows the co-authorship network connecting the top 25 collaborators of Spyros Deftereos. A scholar is included among the top collaborators of Spyros Deftereos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spyros Deftereos. Spyros Deftereos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deftereos, Spyros, George D. Vavougios, Christos Bakirtzis, George Hadjigeorgiou, & Nikolaos Grigoriadis. (2024). Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the ImmuneSynapse: A Systematic Review. Current Pharmaceutical Design. 30(7). 536–551. 1 indexed citations

Tsivgoulis, Georgios, Spyros Deftereos, Claudio Gobbi, et al.. (2022). Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS). SHILAP Revista de lepidopterología. 14. 2669596673–2669596673. 2 indexed citations

Deftereos, Spyros, et al.. (2022). Follitropin Alpha for assisted reproduction: an analysis based on a non-interventional study in Greece. Current Medical Research and Opinion. 38(12). 2227–2235. 1 indexed citations

Deftereos, Spyros, et al.. (2020). Effectiveness of rituximab in treating immune-checkpoint-inhibitor-induced immune-related adverse events: results of a systematic review. Annals of Oncology. 32(2). 282–283. 13 indexed citations

Alexoudi, Athanasia, et al.. (2020). Effects of anodal transcranial direct current stimulation on cognitive dysfunction in patients with progressive supranuclear palsy. Psychiatriki. 30(4). 320–328. 6 indexed citations

Deftereos, Spyros, Effrosyni Koutsouraki, Athanassios P. Kyritsis, et al.. (2018). Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study. BMC Neurology. 18(1). 186–186. 6 indexed citations

Alexoudi, Athanasia, et al.. (2018). Effects of anodal tDCS on motor and cognitive function in a patient with multiple system atrophy. Disability and Rehabilitation. 42(6). 887–891. 10 indexed citations

Deftereos, Spyros & Christos Andronis. (2010). Discordant effects of rasagiline doses in Parkinson disease. Nature Reviews Neurology. 6(7). 410–410. 5 indexed citations

Eleftheriadou, Anna, et al.. (2008). Vestibular evoked myogenic potential eliciting in normal subjects: comparison of four different methods.. PubMed. 37(5). 704–11. 4 indexed citations

10.

Aessopos, Athanassios, et al.. (2007). Intensive Chelation Therapy in β-Thalassemia and Possible Adverse Cardiac Effects of Desferrioxamine. International Journal of Hematology. 86(3). 212–215. 20 indexed citations

11.

Aessopos, Athanassios, Spyros Deftereos, Maria Tsironi, et al.. (2007). Predictive echo-Doppler indices of left ventricular impairment in B-thalassemic patients. Annals of Hematology. 86(6). 429–434. 20 indexed citations

12.

Deftereos, Spyros, et al.. (2005). Identification of echocardiographic indices for the early detection of left-ventricular systolic dysfunction in beta-thalassaemia via Self-Organizing Maps: A data-exploration study. Medical Informatics and the Internet in Medicine. 30(1). 37–53. 1 indexed citations

13.

Tsironi, Maria, Spyros Deftereos, Dimitrios Farmakis, et al.. (2005). Transfusional hemosiderosis and combined chelation therapy in sickle thalassemia. European Journal Of Haematology. 75(4). 355–358. 14 indexed citations

14.

Tassiopoulos, Stergios, et al.. (2005). Does Heterozygous β‐Thalassemia Confer a Protection against Coronary Artery Disease?. Annals of the New York Academy of Sciences. 1054(1). 467–470. 19 indexed citations

15.

Aessopos, Athanasios, Dimitrios Farmakis, Spyros Deftereos, et al.. (2005). Thalassemia Heart Disease. CHEST Journal. 127(5). 1523–1530. 174 indexed citations

16.

Tsironi, Maria, Spyros Deftereos, Panagiotis Andriopoulos, et al.. (2004). Reversal of heart failure in thalassemia major by combined chelation therapy: a case report. European Journal Of Haematology. 74(1). 84–85. 41 indexed citations

17.

Aessopos, Athanasios, Dimitrios Farmakis, Maria Tsironi, et al.. (2004). Hemodynamic assessment of splenomegaly in ?-thalassemia patients undergoing splenectomy. Annals of Hematology. 83(12). 775–778. 15 indexed citations

18.

Farmakis, Dimitrios, et al.. (2003). Unstable angina associated with coronary arterial calcification in a thalassemia intermedia patient with a pseudoxanthoma elasticum‐like syndrome. European Journal Of Haematology. 70(1). 64–66. 16 indexed citations

19.

Deftereos, Spyros, Costas Lambrinoudakis, Panagiotis Andriopoulos, Dimitrios Farmakis, & Athanasios Aessopos. (2001). A Java-based Electronic Healthcare Record Software for Beta-thalassaemia. Journal of Medical Internet Research. 3(4). e33–e33. 9 indexed citations

20.

Deftereos, Spyros, et al.. (1999). Integrating Clinical Care Guidelines With Electronic Healthcare Records. PubMed Central. 1046–1046. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact